Remove Hospice Remove Hospice companies Remove Medicare
article thumbnail

Publicly Traded Hospice Companies Poised for Deals

Hospice News

The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth. Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Case in point, VITAS Healthcare, a subsidiary of Chemed Corp.

article thumbnail

The Public Hospice Companies Most Likely to Acquire in 2024

Hospice News

After a rocky year for M&A, two of the publicly traded hospice providers are poised to pursue more deals in 2024. While the majority of the hospice industry is not publicly traded, the actions of those large companies can have an impact on smaller organizations that are on the hunt for deals. Its hospice segment earned $53.1

professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Blue Sky Hospice Medical Director Convicted of $2.8M Hospice Fraud

Hospice News

A federal jury has convicted Dr. John Thropay, a hospice medical director, on charges of health care fraud in a $2.8 Thropay was the medical director of several hospice companies, including Blue Sky Hospice, based in Van Nuys, California. The post Blue Sky Hospice Medical Director Convicted of $2.8M million scheme.

article thumbnail

FBI Arrests 5 in $15M Hospice Fraud Plot

Hospice News

The FBI has arrested five people in connection with a $15 million hospice fraud and money laundering scheme. The arrests took place in California, a state that has been rife with hospice fraud in recent years, along with Arizona, Texas and Nevada. The post FBI Arrests 5 in $15M Hospice Fraud Plot appeared first on Hospice News.

Hospice 264
article thumbnail

1 at Large, 1 Facing 10 Year Imprisonment in California $30M Hospice Fraud Scheme

Hospice News

A hospice physician in California is facing up to a decade in prison after pleading guilty for their involvement in a kickback fraud scheme that bilked Medicare of nearly $30 million. Contreras served as a physician for two Pasadena-based providers, Saint Mariam Hospice Inc. and Arcadia Hospice Provider Inc.

Hospice 257
article thumbnail

As Headwinds Rage, Large Hospice Companies Lay Groundwork for Potential 2023 Growth

Hospice News

Labor shortages and other headwinds have battered hospices during 2022, including large companies. This year brought the return of Medicare sequestration, and pandemic-driven disruption in referral streams are lingering. This includes the home health and hospice provider Amedisys (NASDAQ: AMED). “On The company saw a 10.6%

article thumbnail

Hospice ‘License Flipping’ Still Plagues Sector, Though Regulations Help

Hospice News

“Shady” brokers allegedly continue to facilitate “license flipping” among fraudulent hospices, though new regulations have started bearing down on the practice. Right now they’re selling like hot tamales from anywhere between $300,000 to $500,000 per license,” one former hospice leader told Hospice News on condition of anonymity.

Hospice 130